15-63601421-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_203373.3(FBXL22):c.479G>T(p.Arg160Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000189 in 1,588,152 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_203373.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL22 | NM_203373.3 | c.479G>T | p.Arg160Leu | missense_variant | 2/2 | NP_976307.2 | ||
FBXL22 | NM_001367809.1 | c.*129G>T | 3_prime_UTR_variant | 3/3 | NP_001354738.1 | |||
FBXL22 | XM_047432400.1 | c.353+3676G>T | intron_variant | XP_047288356.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL22 | ENST00000360587.2 | c.479G>T | p.Arg160Leu | missense_variant | 2/2 | 1 | ENSP00000353794.3 | |||
FBXL22 | ENST00000560325.1 | c.*129G>T | 3_prime_UTR_variant | 3/3 | 3 | ENSP00000473666.1 | ||||
USP3-AS1 | ENST00000561256.5 | n.169C>A | non_coding_transcript_exon_variant | 1/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152200Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000180 AC: 4AN: 222632Hom.: 0 AF XY: 0.0000163 AC XY: 2AN XY: 122482
GnomAD4 exome AF: 0.0000146 AC: 21AN: 1435952Hom.: 0 Cov.: 32 AF XY: 0.0000155 AC XY: 11AN XY: 711934
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74350
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2022 | The c.479G>T (p.R160L) alteration is located in exon 2 (coding exon 2) of the FBXL22 gene. This alteration results from a G to T substitution at nucleotide position 479, causing the arginine (R) at amino acid position 160 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at